Kinase Inhibitors FDA Approved 2018–2023: Drug Targets, Metabolic Pathways, and Drug-Induced Toxicities
BD Latham, RM Geffert, KD Jackson - Drug Metabolism and Disposition, 2024 - ASPET
Small molecule kinase inhibitors are one of the fastest growing classes of drugs, which are
approved by the US Food and Drug Administration (FDA) for cancer and noncancer …
approved by the US Food and Drug Administration (FDA) for cancer and noncancer …